• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 Drp1 可调控乳腺癌细胞对紫杉醇的反应性,但在小鼠中对紫杉醇相关的卵巢损伤无明显缓解作用。

Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.

机构信息

Department of Biochemistry, Faculty of Science, University of Tabuk, 71491, Tabuk, Saudi Arabia.

Division of Biochemistry, Faculty of Science, Tanta University, Tanta City, 31512, Egypt.

出版信息

Sci Rep. 2023 Dec 20;13(1):22782. doi: 10.1038/s41598-023-49578-0.

DOI:10.1038/s41598-023-49578-0
PMID:38129495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10739747/
Abstract

Chemoresistance and chemotherapy-related ovarian damage are well-reported in breast cancer (BC) young patients. Herein, the inhibition of the mitochondrial fission was invested to explore its chemosensitizing role in Paclitaxel (PTX)-resistant cells, and its ability to restore the ovarian integrity in mice receiving PTX or cisplatin chemotherapy. To establish these aims, PTX-resistance was generated in BC cells, which were treated with PTX in combination with Drp1 deficiency, via mdivi-1, or Drp1-specific siRNA transfection. Furthermore, the alterations in the ovarian structure and the endocrine-related hormones were explored in mice receiving repetitive doses of PTX or cisplatin. We found that combining PTX with mdivi-1 improved cell responsiveness to PTX, induced apoptosis- and autophagy-mediated cell death, and relieved cellular oxidative stress. Additionally, the expression of PCNA1 and cyclin B1 genes were downregulated, meanwhile, p53, p21, and mitochondrial fusion proteins (Mfu1&Mfu2) were increased. The in vivo investigations in mice demonstrated that PTX induced gonadotoxic damage similar to cisplatin, whereas dual treatment of mice with PTX+ mdivi-1 failed to restore their normal follicular count and the circulating levels of E2 and AMH hormones. These results suggested that combining Drp1 inhibition with PTX resensitized breast cancer cells to PTX but failed to offer enough protection against chemotherapy-related gonadotoxicity.

摘要

化疗耐药和化疗相关的卵巢损伤在乳腺癌(BC)年轻患者中已有报道。在此,我们研究了线粒体分裂的抑制作用,以探索其在紫杉醇(PTX)耐药细胞中的化疗增敏作用,以及其在接受 PTX 或顺铂化疗的小鼠中恢复卵巢完整性的能力。为了实现这些目标,我们在 BC 细胞中产生了 PTX 耐药性,通过 mdivi-1 联合 Drp1 缺乏、或 Drp1 特异性 siRNA 转染,用 PTX 处理这些细胞。此外,我们还在接受重复剂量的 PTX 或顺铂治疗的小鼠中研究了卵巢结构的改变和与内分泌相关的激素变化。我们发现,将 PTX 与 mdivi-1 联合使用可提高细胞对 PTX 的反应性,诱导凋亡和自噬介导的细胞死亡,并减轻细胞氧化应激。此外,PCNA1 和 cyclin B1 基因的表达下调,同时 p53、p21 和线粒体融合蛋白(Mfu1 和 Mfu2)增加。在接受重复剂量的 PTX 或顺铂治疗的小鼠的体内研究表明,PTX 诱导的性腺毒性损伤与顺铂相似,而用 PTX+mdivi-1 双重处理小鼠未能恢复其正常的卵泡计数和 E2 和 AMH 激素的循环水平。这些结果表明,抑制 Drp1 与 PTX 联合使用可使乳腺癌细胞对 PTX 重新敏感,但不能为化疗相关的性腺毒性提供足够的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/dc811ac4b4a9/41598_2023_49578_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/116364e09858/41598_2023_49578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/e3dfc23dcee2/41598_2023_49578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/1fb00bd68298/41598_2023_49578_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/84534909c1df/41598_2023_49578_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/e13d54290bfb/41598_2023_49578_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/71bde6ff5100/41598_2023_49578_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/dc811ac4b4a9/41598_2023_49578_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/116364e09858/41598_2023_49578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/e3dfc23dcee2/41598_2023_49578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/1fb00bd68298/41598_2023_49578_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/84534909c1df/41598_2023_49578_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/e13d54290bfb/41598_2023_49578_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/71bde6ff5100/41598_2023_49578_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/10739747/dc811ac4b4a9/41598_2023_49578_Fig7_HTML.jpg

相似文献

1
Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.抑制 Drp1 可调控乳腺癌细胞对紫杉醇的反应性,但在小鼠中对紫杉醇相关的卵巢损伤无明显缓解作用。
Sci Rep. 2023 Dec 20;13(1):22782. doi: 10.1038/s41598-023-49578-0.
2
Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.长链非编码 RNA ZEB1-AS1 通过调节上皮性卵巢癌细胞中的 MMP19 影响紫杉醇和顺铂耐药性。
Arch Gynecol Obstet. 2021 May;303(5):1271-1281. doi: 10.1007/s00404-020-05858-y. Epub 2020 Nov 5.
3
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.紫杉醇耐药卵巢癌细胞系中侧群细胞增加,而与顺铂耐药无关。
Gynecol Oncol. 2011 May 1;121(2):390-4. doi: 10.1016/j.ygyno.2010.12.366. Epub 2011 Jan 26.
4
Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.通关藤注射液通过上调TAB1表达在体内外逆转卵巢癌对紫杉醇的耐药性。
J Ethnopharmacol. 2023 Jan 10;300:115728. doi: 10.1016/j.jep.2022.115728. Epub 2022 Sep 17.
5
Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.靶向抑制磷脂酰肌醇-3-激酶 p110β,而非 p110α,可增强耐药性卵巢癌的细胞凋亡并提高对紫杉醇的敏感性。
Apoptosis. 2013 Apr;18(4):509-20. doi: 10.1007/s10495-013-0807-9.
6
Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.环状 RNA-RNF111 通过 miR-140-5p 升高 E2F3 表达促进乳腺癌对紫杉醇耐药。
Thorac Cancer. 2020 Jul;11(7):1891-1903. doi: 10.1111/1759-7714.13475. Epub 2020 May 23.
7
Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.紫杉醇诱导卵巢癌细胞系及其紫杉醇耐药克隆凋亡的机制。
Oncology. 2004;66(1):53-61. doi: 10.1159/000076335.
8
Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells.从苦瓜叶中分离出的苦瓜素J可调节耐药性人卵巢癌细胞对紫杉醇的敏感性。
J Nat Med. 2017 Oct;71(4):693-702. doi: 10.1007/s11418-017-1099-0. Epub 2017 Jun 21.
9
MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.miR-21-5p 通过靶向 PDCD4 增强耐药乳腺癌细胞系的进展和紫杉醇耐药性。
Neoplasma. 2019 Jun 3;66(5):746-755. doi: 10.4149/neo_2018_181207N930. Print 2019 Sep.
10
MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.miR-138-5p 增强 MDA-MB-231 乳腺癌细胞系对紫杉醇的化疗敏感性。
Mol Biol Rep. 2023 Oct;50(10):8407-8420. doi: 10.1007/s11033-023-08711-y. Epub 2023 Aug 24.

引用本文的文献

1
Role of mitochondria in physiological activities, diseases, and therapy.线粒体在生理活动、疾病及治疗中的作用。
Mol Biomed. 2025 Jun 19;6(1):42. doi: 10.1186/s43556-025-00284-5.
2
DRP1: shedding light on the complex nexus of mitochondrial fission and breast cancer.动力相关蛋白1:揭示线粒体裂变与乳腺癌之间的复杂关系
Future Oncol. 2025 Feb;21(5):593-603. doi: 10.1080/14796694.2024.2447813. Epub 2024 Dec 29.

本文引用的文献

1
Correction: Drp1 modulates mitochondrial stress responses to mitotic arrest.更正:动力相关蛋白1(Drp1)调节线粒体对有丝分裂停滞的应激反应。
Cell Death Differ. 2022 Oct;29(10):2105. doi: 10.1038/s41418-021-00831-x.
2
Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells.Mdivi-1可诱导MDA-MB-231细胞出现纺锤体异常并增强紫杉醇的细胞毒性。
Cell Death Discov. 2021 May 20;7(1):118. doi: 10.1038/s41420-021-00495-z.
3
Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch.
Mdivi-1,一种线粒体分裂抑制剂,通过介导 VSMC 表型转换来减少血管紧张素-II 诱导的高血压。
Biomed Pharmacother. 2021 Aug;140:111689. doi: 10.1016/j.biopha.2021.111689. Epub 2021 May 15.
4
Inhibition of Drp1 Sensitizes Cancer Cells to Cisplatin-Induced Apoptosis through Transcriptional Inhibition of c-FLIP Expression.通过抑制 c-FLIP 的转录表达,Drp1 抑制剂增敏癌细胞对顺铂诱导的细胞凋亡。
Molecules. 2020 Dec 8;25(24):5793. doi: 10.3390/molecules25245793.
5
Transient impact of paclitaxel on mouse fertility and protective effect of gonadotropin‑releasing hormone agonist.紫杉醇对小鼠生育力的短暂影响及促性腺激素释放激素激动剂的保护作用。
Oncol Rep. 2020 Nov;44(5):1917-1928. doi: 10.3892/or.2020.7740. Epub 2020 Aug 19.
6
The Therapeutic Effect of Stem Cells on Chemotherapy-Induced Premature Ovarian Failure.干细胞对化疗诱导的卵巢早衰的治疗作用。
Curr Mol Med. 2021;21(5):376-384. doi: 10.2174/1566524020666200905113907.
7
NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.NSAS-BC02 子研究:接受单独紫杉烷类或蒽环类(A)环磷酰胺(C)序贯紫杉烷类作为术后化疗的绝经前患者的化疗诱导闭经(CIA)。
Breast Cancer Res Treat. 2020 Jul;182(2):325-332. doi: 10.1007/s10549-020-05692-5. Epub 2020 May 28.
8
Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer.线粒体分裂抑制剂(mdivi-1)可降低癌症中的氧化代谢。
Br J Cancer. 2020 Apr;122(9):1288-1297. doi: 10.1038/s41416-020-0778-x. Epub 2020 Mar 9.
9
Altered Mitochondrial Dynamics, Biogenesis, and Functions in the Paclitaxel-Resistant Lung Adenocarcinoma Cell Line A549/Taxol.紫杉醇耐药肺腺癌细胞系A549/Taxol中线粒体动力学、生物发生及功能的改变
Med Sci Monit. 2020 Mar 4;26:e918216. doi: 10.12659/MSM.918216.
10
Highlights in Resistance Mechanism Pathways for Combination Therapy.联合治疗的耐药机制途径亮点。
Cells. 2019 Aug 30;8(9):1013. doi: 10.3390/cells8091013.